A detailed history of Td Waterhouse Canada Inc. transactions in Organon & Co. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 7,532 shares of OGN stock, worth $113,431. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,532
Previous 7,557 0.33%
Holding current value
$113,431
Previous $153 Million 7.48%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$18.65 - $23.03 $466 - $575
-25 Reduced 0.33%
7,532 $142 Million
Q2 2024

Nov 12, 2024

SELL
$17.45 - $21.96 $6,351 - $7,993
-364 Reduced 4.6%
7,557 $153 Million
Q2 2024

Aug 02, 2024

SELL
$17.45 - $21.96 $1,099 - $1,383
-63 Reduced 0.79%
7,921 $192 Million
Q1 2024

May 10, 2024

SELL
$13.78 - $18.8 $64,311 - $87,739
-4,667 Reduced 36.89%
7,984 $147 Million
Q4 2023

Feb 12, 2024

SELL
$10.95 - $17.32 $31,371 - $49,621
-2,865 Reduced 18.46%
12,651 $178 Million
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $317,416 - $454,791
-19,133 Reduced 55.22%
15,516 $266 Million
Q2 2023

Nov 13, 2023

SELL
$19.27 - $24.63 $792,247 - $1.01 Million
-41,113 Reduced 54.27%
34,649 $733 Million
Q1 2023

Nov 13, 2023

BUY
$21.42 - $32.08 $39,434 - $59,059
1,841 Added 2.49%
75,762 $1.85 Billion
Q4 2022

Nov 13, 2023

SELL
$23.31 - $28.61 $1,631 - $2,002
-70 Reduced 0.09%
73,921 $2.16 Billion
Q3 2022

Nov 13, 2023

BUY
$23.4 - $34.25 $18,439 - $26,989
788 Added 1.08%
73,991 $1.85 Billion
Q2 2022

Nov 13, 2023

BUY
$31.66 - $38.9 $35,839 - $44,034
1,132 Added 1.57%
73,203 $2.58 Billion
Q1 2022

Nov 13, 2023

BUY
$30.45 - $39.36 $345,698 - $446,854
11,353 Added 18.7%
72,071 $2.61 Billion
Q4 2021

Nov 13, 2023

BUY
$28.67 - $37.13 $1.74 Million - $2.25 Million
60,718 New
60,718 $1.98 Billion

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.83B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.